SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (551)12/21/2004 11:01:02 AM
From: rkrw  Read Replies (1) of 625
 
<<<My guess is rkrw's report said, or meant, the incremental increase in royalty is up to ~2.1% (from 1%).>>>

That's not what it said. Incremental increase in royalty of 1.4%, based on going from 2% (0.7% net of mrc) to 5% (2.1% net of mrc). I'll post the details when I have access to my home pc tomorrow. Keep in mind, I can't vouch for the analysts accuracy or necessarily my memory :-)

catg royalty deal with mrc has nothing to do with abt, so no excuse not to be fully transparent on this. At least exel can claim gsk made them promise to keep it secret :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News